Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 5.64% is 30% above its 5-year average of 4.33%, near the high end of its 5-year range (0.99%–7.31%).
15.63% below its 12-month average of 6.68%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
5.64%
RETURN ON ASSETS (ROA) AVG TTM
6.68%
RETURN ON ASSETS (ROA) AVG 3Y
4.44%
RETURN ON ASSETS (ROA) AVG 5Y
4.33%
RETURN ON ASSETS (ROA) AVG 10Y
4.48%
RETURN ON ASSETS (ROA) AVG 15Y
5.31%
RETURN ON ASSETS (ROA) AVG 20Y
5.87%
CURRENT VS TTM AVG
-15.63%
CURRENT VS 3Y AVG
+26.88%
CURRENT VS 5Y AVG
+30.40%
CURRENT VS 10Y AVG
+25.79%
CURRENT VS 15Y AVG
+6.20%
CURRENT VS 20Y AVG
-3.99%
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+14.17%
vs the sector median at left
Market Cap
$23.41B
Return on Assets (ROA)
-6.03%
TTM Avg
-3.96%
3Y Avg
9.16%
5Y Avg
17.06%
Market Cap
$23.66B
Return on Assets (ROA)
-28.75%
TTM Avg
-24.02%
3Y Avg
-10.32%
5Y Avg
-0.33%
Market Cap
$22.26B
Return on Assets (ROA)
18.16%
TTM Avg
16.59%
3Y Avg
14.73%
5Y Avg
13.22%
Market Cap
$24.84B
Return on Assets (ROA)
20.48%
TTM Avg
9.54%
3Y Avg
8.43%
5Y Avg
7.44%
Market Cap
$25.06B
Return on Assets (ROA)
13.86%
TTM Avg
12.54%
3Y Avg
14.20%
5Y Avg
14.86%
Market Cap
$26.25B
Return on Assets (ROA)
6.27%
TTM Avg
5.75%
3Y Avg
6.24%
5Y Avg
8.30%
Market Cap
$26.27B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
Market Cap
$19.04B
Return on Assets (ROA)
-1.17%
TTM Avg
-5.49%
3Y Avg
-1.68%
5Y Avg
-1.68%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $23.06B | 5.64% | 6.68% | 4.44% | 4.33% |
| BioNTech SE (BNTX)vs › | $23.41B | -6.03% | -3.96% | 9.16% | 17.06% |
| Moderna, Inc. (MRNA)vs › | $23.66B | -28.75% | -24.02% | -10.32% | -0.33% |
| United Therapeutics Corporation (UTHR)vs › | $22.26B | 18.16% | 16.59% | 14.73% | 13.22% |
| Incyte Corporation (INCY)vs › | $24.84B | 20.48% | 9.54% | 8.43% | 7.44% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.06B | 13.86% | 12.54% | 14.20% | 14.86% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.25B | 6.27% | 5.75% | 6.24% | 8.30% |
| Labcorp Holdings Inc. (LH)vs › | $26.27B | 5.41% | 4.41% | 4.42% | 6.18% |
| Viatris Inc. (VTRS)vs › | $19.04B | -1.17% | -5.49% | -1.68% | -1.68% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.69B | 3.54% | 3.64% | 3.29% | 2.38% |
ROA
5.6%
ROE
8.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-03-31 | 7.31% |
| 2025-03-31 | 6.06% |
| 2024-03-31 | 3.42% |
| 2023-03-31 | 0.99% |
| 2022-03-31 | 2.13% |
| 2021-03-31 | 6.04% |
| 2020-03-31 | 7.49% |
| 2019-03-31 | 5.99% |
| 2018-03-31 | 5.59% |
| 2017-03-31 | 2.23% |
| 2016-03-31 | 2.07% |
| 2015-03-31 | 6.44% |
| 2014-03-31 | 6.86% |
| 2013-03-31 | 9.08% |
| 2012-03-31 | 9.68% |
| 2011-03-31 | 3.59% |
| 2010-03-31 | 10.37% |
| 2009-03-31 | 9.10% |
| 2008-03-31 | 6.22% |
| 2007-03-31 | 6.79% |
| 2006-03-31 | 5.91% |
| 2005-03-31 | 7.25% |
| 2004-03-31 | 8.82% |
| 2003-03-31 | 8.88% |
| 2002-03-31 | 5.49% |
| 2001-03-31 | 0.16% |
| 2000-03-31 | 1.16% |
| 1999-03-31 | 9.80% |
| 1998-03-31 | 8.94% |
| 1997-03-31 | -5.67% |
